ANDA 65115, held by Sun Pharm Inds Ltd. Cefadroxil/Cefadroxil Hemihydrate.
As of Nov 16, 2026, ANDA 65115 (Cefadroxil), held by Sun Pharm Inds Ltd, was first approved by FDA on Mar 26, 2003, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 26, 2003 | Original application | Approved |
| CefadroxilEQ 125MG BASE/5ML · for suspension;oral | Cefadroxil/Cefadroxil Hemihydrate | Discontinued |
| CefadroxilEQ 250MG BASE/5ML · for suspension;oral | Cefadroxil/Cefadroxil Hemihydrate | Discontinued |
| CefadroxilEQ 500MG BASE/5ML · for suspension;oral | Cefadroxil/Cefadroxil Hemihydrate | Discontinued |
| Apr 25, 2008 | Supplement 9Labeling | Approved | None posted |
| Jul 23, 2007 | Supplement 5Labeling | Approved | None posted |
| Oct 4, 2004 | Supplement 1Labeling | Approved | None posted |
| Mar 26, 2003 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters